Drug Shortage Report for TEVA-ALENDRONATE/CHOLECALCIFEROL
| Report ID | 23146 |
| Drug Identification Number | 02403641 |
| Brand name | TEVA-ALENDRONATE/CHOLECALCIFEROL |
| Common or Proper name | ALENDRONATE VIT D |
| Company Name | TEVA CANADA LIMITED |
| Market Status | DORMANT |
| Active Ingredient(s) | ALENDRONIC ACID VITAMIN D3 |
| Strength(s) | 70MG 5600UNIT |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 4 |
| ATC code | M05BB |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2017-11-20 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2018-12-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2018-10-11 | French | Compare |
| v6 | 2018-10-11 | English | Compare |
| v5 | 2018-01-03 | French | Compare |
| v4 | 2018-01-03 | English | Compare |
| v3 | 2017-11-21 | English | Compare |
| v2 | 2017-09-22 | French | Compare |
| v1 | 2017-09-22 | English | Compare |
Showing 1 to 7 of 7